Correlation Between Khiron Life and Sangui Biotech
Can any of the company-specific risk be diversified away by investing in both Khiron Life and Sangui Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Khiron Life and Sangui Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Khiron Life Sciences and Sangui Biotech International, you can compare the effects of market volatilities on Khiron Life and Sangui Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Khiron Life with a short position of Sangui Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Khiron Life and Sangui Biotech.
Diversification Opportunities for Khiron Life and Sangui Biotech
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Khiron and Sangui is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Khiron Life Sciences and Sangui Biotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangui Biotech Inter and Khiron Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Khiron Life Sciences are associated (or correlated) with Sangui Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangui Biotech Inter has no effect on the direction of Khiron Life i.e., Khiron Life and Sangui Biotech go up and down completely randomly.
Pair Corralation between Khiron Life and Sangui Biotech
If you would invest 0.02 in Sangui Biotech International on December 28, 2024 and sell it today you would earn a total of 0.00 from holding Sangui Biotech International or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.24% |
Values | Daily Returns |
Khiron Life Sciences vs. Sangui Biotech International
Performance |
Timeline |
Khiron Life Sciences |
Sangui Biotech Inter |
Khiron Life and Sangui Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Khiron Life and Sangui Biotech
The main advantage of trading using opposite Khiron Life and Sangui Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Khiron Life position performs unexpectedly, Sangui Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangui Biotech will offset losses from the drop in Sangui Biotech's long position.Khiron Life vs. Blueberries Medical Corp | Khiron Life vs. Speakeasy Cannabis Club | Khiron Life vs. City View Green | Khiron Life vs. Benchmark Botanics |
Sangui Biotech vs. Assertio Therapeutics | Sangui Biotech vs. Amneal Pharmaceuticals, Class | Sangui Biotech vs. Lifecore Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |